Effects of a glucokinase activator on hepatic intermediary metabolism: study with 13C-isotopomer-based metabolomics.
about
The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic ratsNovel and emerging diabetes mellitus drug therapies for the type 2 diabetes patientAnalysis of the co-operative interaction between the allosterically regulated proteins GK and GKRP using tryptophan fluorescenceFructose-1,6-bisphosphatase opposes renal carcinoma progressionInheritance of rare functional GCKR variants and their contribution to triglyceride levels in families.Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors.The molecular and metabolic influence of long term agmatine consumptionGlucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism.Phosphorus ingestion improves oral glucose tolerance of healthy male subjects: a crossover experimentMitochondrial functions modulate neuroendocrine, metabolic, inflammatory, and transcriptional responses to acute psychological stressRegulation of brain glutamate metabolism by nitric oxide and S-nitrosylationSmall molecular glucokinase activators: has another new anti-diabetic therapeutic lost favour?Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes.Antidiabetic agents: past, present and future.MITOsym®: A Mechanistic, Mathematical Model of Hepatocellular Respiration and Bioenergetics.Glucokinase activation is beneficial or toxic to cultured rat pancreatic islets depending on the prevailing glucose concentration.Diabetes - the Role of Metabolomics in the Discovery of New Mechanisms and Novel Biomarkers
P2860
Q27333171-4298B58B-94BA-415E-B492-E339F92AAB5FQ33759570-00B8E0FE-73E9-414E-884A-74648E6F72F8Q33945387-330AB6B5-F70A-4529-85B7-1DC772C6C70BQ34173576-8CAC47A8-54FD-4F0D-BE81-A974F7DDD9FFQ34211860-1316B1BC-A102-420A-8C77-ECA7A14B1157Q34339449-20725656-775E-49B9-976B-C8283BD34127Q34403988-7D511E6B-BBA6-42FB-9E36-E5D7458F01AFQ35578341-3D2422F7-3E29-4E73-8D1A-1E566DC7A782Q36233027-301B1BAB-AF2D-40F9-8471-90F5064EFC69Q36354896-5A2B13F6-56E4-4874-9913-D0234AEB3D41Q36560287-5247B863-36EC-4AF9-8EFB-B88573FAB998Q36610334-12667F9E-B749-4C56-B86C-0A085F5D0260Q37665590-E6F65C7A-E416-4EC6-A574-993287FA5228Q38089737-351EEDB1-6231-4465-BF35-0D8C1798D83AQ40376380-1815D264-F4F3-428A-A450-3CFB42414894Q48147688-5113CCF1-9F53-45F1-8308-52E5DC105753Q57797336-19C9AE7D-6C8E-4059-ABF0-56091D3E1BFB
P2860
Effects of a glucokinase activator on hepatic intermediary metabolism: study with 13C-isotopomer-based metabolomics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effects of a glucokinase activ ...... isotopomer-based metabolomics.
@en
type
label
Effects of a glucokinase activ ...... isotopomer-based metabolomics.
@en
prefLabel
Effects of a glucokinase activ ...... isotopomer-based metabolomics.
@en
P2093
P2860
P356
P1433
P1476
Effects of a glucokinase activ ...... isotopomer-based metabolomics.
@en
P2093
Franz M Matschinsky
Ilana Nissim
Itzhak Nissim
Marc Yudkoff
Oksana Horyn
Suzanne L Wehrli
Yevgeny Daikhin
P2860
P304
P356
10.1042/BJ20120163
P407
P577
2012-06-01T00:00:00Z